RTKN2 and hepatocellular carcinoma: Furthermore, researchers identified that hsa_circ_104348 positively regulates expression of rhotekin-2 (RTKN2) and activates the Wnt/β-catenin signaling pathway by sponging miR-187-3p to promote HCC progression (66).